Sanofi

OTC: SNYNF · Real-Time Price · USD
101.05
2.93 (2.99%)
At close: Aug 15, 2025, 2:18 PM
98.12
-2.90%
After-hours: Aug 13, 2025, 08:00 PM EDT

Sanofi Balance Sheet Statement

Financials in EUR. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
7.44B 8.71B 12.74B 10.1B
Short-Term Investments
486M 270M 664M 1.05B
Long-Term Investments
3.26B 2.67B 9.15B 7.97B
Other Long-Term Assets
1.37B 13.63B -5.14B -4.42B
Receivables
10.63B 11.04B 10.75B 9.79B
Inventory
9.43B 9.67B 20.92B 19.85B
Other Current Assets
13.71B 216M 291M 384M
Total Current Assets
42.59B 30.67B 34.11B 30.65B
Property-Plant & Equipment
11.6B 11.81B 11.68B 11.98B
Goodwill & Intangibles
66.01B 67.69B 69.39B 69.46B
Total Long-Term Assets
90.21B 95.79B 90.47B 89.59B
Total Assets
132.8B 126.46B 124.58B 120.24B
Account Payables
7.55B 7.33B 6.81B 6.18B
Deferred Revenue
n/a n/a 264M 319M
Short-Term Debt
4.21B 2.04B 4.17B 3.18B
Other Current Liabilities
15.13B 12.62B 10.73B 10.05B
Total Current Liabilities
29.16B 24.21B 23.97B 21.3B
Long-Term Debt
11.79B 14.35B 14.86B 17.12B
Other Long-Term Liabilities
10.18B 11.8B 2.02B 2.19B
Total Long-Term Liabilities
25.78B 27.9B 27.1B 29.92B
Total Liabilities
54.94B 52.11B 51.07B 51.21B
Total Debt
17.91B 18.42B 21.21B 22.41B
Common Stock
2.53B 2.53B 2.52B 2.53B
Retained Earnings
n/a n/a 66.73B 63.01B
Comprehensive Income
70.56B 67.44B 68.19B 62.16B
Shareholders Equity
77.51B 74.04B 73.14B 68.68B
Total Investments
3.75B 2.94B 9.82B 9.03B